U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.